admiss
patient
chest
ct
show
pneumonia
includ
asymptomat
patient
patient
show
bilater
infiltr
group
averag
age
year
old
durat
onset
hospit
day
compar
group
age
older
durat
longer
p
asymptomat
patient
day
group
patient
releas
quarantin
white
blood
cell
count
patient
lymphocyt
count
patient
absolut
count
white
blood
cell
lymphocyt
respect
compar
admiss
p
major
case
studi
area
mild
moder
good
clinic
outcom
special
characterist
clinic
process
reason
durat
onset
releas
quarantin
complex
signific
chang
number
granulocyt
time
releas
quarantin
compar
time
admiss
previou
articl
introduc
clinic
characterist
outcom
mainli
earli
case
hubei
provinc
especi
wuhan
due
limit
insuffici
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
medic
condit
time
certain
impact
outcom
treatment
covid
clinic
characterist
outcom
patient
hubei
provinc
outsid
hubei
provinc
differ
articl
earli
clinic
characterist
covid
patient
outsid
hubei
provinc
number
small
articl
describ
earli
clinic
characterist
liaocheng
citi
middl
east
china
prefecturelevel
citi
shandong
provinc
popul
million
region
outsid
hubei
provinc
similar
differ
characterist
case
hubei
provinc
even
countri
region
besid
special
rule
patient
releas
quarantin
long
time
diagnosi
releas
quarantin
sever
case
determin
accord
protocol
diagnosi
treatment
novel
coronaviru
pneumonia
issu
nation
health
administr
tradit
chines
medicin
confirm
case
defin
posit
result
realtim
reversetranscriptas
polymerasechainreact
rtpcr
assay
nasal
pharyng
swab
specimen
criteria
case
releas
quarantin
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
recommend
protocol
start
follow
three
bodi
temperatur
return
normal
day
respiratori
symptom
improv
significantli
pulmonari
imag
show
signific
absorpt
acut
exud
lesion
basi
strict
nucleic
acid
neg
test
standard
day
hospit
everi
day
test
nucleic
acid
test
neg
case
instead
everi
hour
test
three
consecut
test
neg
releas
quarantin
dynam
test
nucleic
acid
neg
case
posit
suspici
step
restart
case
kept
hospit
day
releas
quarantin
sever
case
identifi
accord
respiratori
criteria
exclud
meet
respiratori
criteria
requir
intens
manag
patient
one
month
old
patient
identifi
screen
releas
quarantin
day
hospit
exclud
analysi
patient
adult
incub
period
consid
characterist
patient
studi
time
first
infect
novel
coronaviru
difficult
precis
discuss
studi
retrospect
analyz
gener
characterist
epidemiolog
histori
chronic
underli
diseas
clinic
symptom
complic
chest
ct
biochem
monitor
sever
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
assess
treatment
plan
outcom
patient
result
examin
studi
time
node
report
hour
patient
lack
serum
amyloid
saa
creactiv
protein
crp
admiss
patient
lack
erythrocyt
sediment
rate
esr
admiss
exclud
correspond
item
statist
addit
patient
divid
group
group
accord
durat
releas
quarantin
similar
differ
two
group
clinic
process
compar
order
find
relev
factor
nucleic
acid
continu
posit
continu
variabl
express
mean
standard
deviat
median
interquartil
rang
iqr
appropri
categor
variabl
summar
count
percentag
categori
test
wilcoxon
ranksum
test
appli
continu
variabl
fisher
exact
test
use
categor
variabl
wilcoxon
rank
sum
test
use
rank
classif
variabl
analys
conduct
spss
softwar
version
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
low
fever
abnorm
platelet
creatin
kinas
creatinin
observ
routin
blood
biochemistri
admiss
tabl
treatment
patient
acut
respiratori
distress
syndrom
ard
mild
moder
given
highflow
nasal
group
age
older
length
stay
onset
hospit
longer
p
clinic
symptom
admiss
asymptomat
patient
day
group
symptom
fatigu
sore
throat
short
breath
higher
group
tabl
patient
treat
albumin
thymu
peptid
tabl
ii
longer
hospit
stay
tabl
iii
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
small
number
case
studi
affect
statist
analysi
result
still
show
mani
obviou
characterist
patient
mainli
mild
moder
sever
case
critic
case
final
patient
releas
quarantin
without
death
clinic
outcom
significantli
better
hubei
provinc
main
reason
may
patient
rel
mild
avail
adequ
medic
facil
personnel
made
patient
less
like
develop
sever
critic
condit
hospit
patient
stratifi
accord
psi
may
better
strategi
improv
outcom
patient
especi
outbreak
medic
resourc
rel
insuffici
although
proport
patient
chronic
underli
diseas
group
serious
affect
outcom
sinc
patient
around
year
old
accord
epidemiolog
histori
patient
studi
direct
contact
confirm
patient
workplac
meet
conceptu
standard
close
contact
suggest
exist
transmiss
rout
covid
aerosol
among
patient
proport
asymptomat
patient
account
total
patient
patient
chest
ct
scan
still
show
pneumonia
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
decreas
white
blood
cell
lymphocyt
count
among
first
symptom
admiss
proport
short
breath
gastrointestin
symptom
high
could
exclud
influenc
psycholog
factor
addit
proport
patient
fever
high
fever
mainli
low
characterist
differ
highli
infecti
respiratori
viru
infect
among
routin
blood
biochemistri
admiss
common
reduct
lymphocyt
count
nearli
half
patient
number
white
blood
cell
count
mostli
normal
less
third
patient
lower
abnorm
rel
high
proport
esr
albumin
saa
crp
chang
slight
less
specif
thu
decreas
lymphocyt
count
may
import
monitor
routin
biochem
test
chang
chest
ct
group
similar
studi
significantli
differ
characterist
pneumonia
treatment
measur
patient
group
mainli
accord
protocol
although
patient
mainli
mild
moder
treatment
complic
due
particular
epidem
twothird
patient
given
antibiot
although
enough
evid
bacteri
infect
although
specif
antivir
drug
recommend
patient
group
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
routin
given
antivir
drug
twothird
given
two
antivir
drug
onethird
given
three
antivir
drug
effect
thymosin
glucocorticoid
albumin
immunoglobulin
need
investig
especi
mild
moder
patient
mani
studi
demonstr
import
role
tcm
inhibit
coronaviru
although
patient
studi
mainli
mild
moder
still
signific
differ
durat
onset
releas
form
quarantin
import
basi
releas
quarantin
persist
neg
nucleic
acid
test
result
durat
onset
releas
form
quarantin
reflect
time
take
patient
releas
viru
respiratori
tract
averag
time
onset
releas
form
quarantin
day
sinc
patient
could
releas
quarantin
three
consecut
neg
nucleic
acid
test
result
test
interv
hour
incub
period
report
previou
literatur
consid
averag
durat
viru
releas
studi
similar
professor
cao
bin
studi
item
group
group
significantli
differ
may
reason
quarantin
releas
long
time
age
group
older
time
onset
admiss
later
suggest
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
although
specif
antivir
drug
systemat
support
treatment
admiss
could
improv
outcom
even
mild
moder
patient
differ
psi
score
chronic
underli
diseas
epidemiolog
histori
admiss
two
group
possibl
due
small
number
case
mild
ill
symptom
admiss
asymptomat
patient
screen
recov
quickli
may
relat
viral
load
individu
differ
symptomat
patient
fatigu
pharyng
pain
obviou
patient
group
unknown
reason
term
routin
blood
biochem
examin
pulmonari
imag
although
abnorm
proport
individu
indic
group
higher
group
number
sampl
larg
enough
suffici
clinic
signific
signific
differ
number
patient
two
group
relat
fact
almost
patient
mild
moder
one
critic
ill
patient
quickli
releas
quarantin
clinic
result
may
suggest
cross
relationship
sustain
posit
nucleic
acid
novel
coronaviru
respiratori
tract
specimen
sever
diseas
linear
relationship
reason
sustain
posit
nucleic
acid
complex
group
use
drug
may
relat
eager
make
patient
nucleic
acid
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
neg
particular
signific
improv
white
blood
cell
lymphocyt
count
time
releas
quarantin
time
admiss
either
day
group
day
group
reason
need
studi
number
case
studi
larg
obviou
region
characterist
diseas
mainli
mild
moder
repres
characterist
larg
number
patient
larg
geograph
rang
also
repres
sever
critic
patient
case
liaocheng
citi
mild
moder
main
caus
infect
exposur
confirm
patient
workplac
confirm
patient
main
clinic
symptom
cough
fever
fatigu
short
breath
sore
throat
gastrointestin
symptom
also
common
chest
ct
scan
show
pneumonia
reduc
lymphocyt
count
import
adjunct
examin
durat
releas
quarantin
relat
age
length
time
onset
admiss
presenc
absenc
symptom
relat
mild
normal
type
signific
improv
white
blood
cell
lymphocyt
count
time
releas
quarantin
compar
time
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
admiss
